Digitally Signed Document Document ID: 5585670C3927C2 ## Document Details: **----- Start of picture text -----**
Filename: Clinical Research Trust - ACC 2022.pdf
Client of: Sandison Lang
Signature Details
Name: Paul Ciclitira
Email: pciclitira@btinternet.com
Date & Time: 23/05/2022 12:02:16 (BST)
IP Address: 86.150.120.139
Paul Ciclitira confirms that the information is correct and
Signing Statement:
complete to the best of their knowledge and belief.
**----- End of picture text -----**
## Digital Certificate The approved PDF file has been digitally certified. Please check the Digital Certificate information in your PDF viewer to verify the Digital Certificate authenticity and the PDF has not been tampered with. **----- Start of picture text -----**
On behalf of: Sandison Lang
PDF digital certificate: IRIS Software Group Limited
Digital certificate issued by: GlobalSign
**----- End of picture text -----**
Please keep a copy of this document for your records. **REGISTERED CHARITY NUMBER: 1010090** **Report of the Trustees and** **Unaudited Financial Statements** **for the Year Ended 5 April 2022** ## **for** ## **CLINICAL RESEARCH TRUST** Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB **CLINICAL RESEARCH TRUST** **Contents of the Financial Statements for the Year Ended 5 April 2022** **----- Start of picture text -----**
Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 10
Detailed Statement of Financial Activities 11
**----- End of picture text -----**
**CLINICAL RESEARCH TRUST** **Report of the Trustees for the Year Ended 5 April 2022** The trustees present their report with the financial statements of the charity for the year ended 5 April 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** The object ives of the Trust is the promotion of Clinical and Fundamental Research into the causes and treatment of clinical diseases on terms that the results of such research are published.. ## **Current activities** The Clinical Research Trust has moved its support to the work undertaken by the Norwich Medical School in the University of East Anglia. The research has focused on work to improve the knowledge of the pathogenesis of the condition, characterisation of toxic epitopes in wheat and method to measure these cereals in foods to individuals with coeliac disease. The Trust continues to improve the treatment and provide a better understanding of the condition and the pathogenesis to help the 670,000 affected subjects in the UK, including children and millions more worldwide to improve not only their treatment, but also to improve their quality of life. ## **FINANCIAL REVIEW** ## **Reserves policy** The Trust maintains a reserve sufficient to meet its annual demands. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity. ## **Risk management** The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Charity number** 1010090 ## **Principal address** 25 Penzance Street Holland Park London W11 4QX Page 1 **CLINICAL RESEARCH TRUST** ## **Report of the Trustees for the Year Ended 5 April 2022** ## **Trustees** Professor E K Sikora Professor P J Ciclitira ## **Independent Examiner** Miss Francine Hamilton ACCA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB Approved by order of the board of trustees on ............................................. and signed on its behalf by: ................................................................. Professor P J Ciclitira - Trustee Page 2 **Independent Examiner's Report to the Trustees of Clinical Research Trust** ## **Independent examiner's report to the trustees of Clinical Research Trust** I report to the charity trustees on my examination of the accounts of Clinical Research Trust (the Trust) for the year ended 5 April 2022. ## **Responsibilities and basis of report** As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act'). I report in respect of my examination of the Trust's accounts carried out under section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. ## **Independent examiner's statement** I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Miss Francine Hamilton ACCA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB Date: ............................................. Page 3 **CLINICAL RESEARCH TRUST** ## **Statement of Financial Activities for the Year Ended 5 April 2022** |**2022**
**Unrestricted**
**fund**
Notes
**£**
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
**27,166**
**EXPENDITURE ON**
**Charitable activities**
Grants
**27,140**
Other
**(24)**
**Total**
**27,116**
**NET INCOME/(EXPENDITURE)**
**50**
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
**1,347**
**TOTAL FUNDS CARRIED FORWARD**
**1,397**|2021
Total
funds
£
50,377
49,540
873
50,413
(36)
1,383
1,347| |---|---| The notes form part of these financial statements Page 4 **CLINICAL RESEARCH TRUST** ## **Balance Sheet 5 April 2022** |Notes
**FIXED ASSETS**
Investments
4
**CURRENT ASSETS**
Cash at bank
**CREDITORS**
Amounts falling due within one year
5|**2022**
**Unrestricted**
**fund**
**£**
**2,160**
**5**
**(768)**|2021
Total
funds
£
2,160
891
(1,704)| |---|---|---| |**NET CURRENT ASSETS**|**(763)**|(813)| |**TOTAL ASSETS LESS CURRENT LIABILITIES**|**1,397**|1,347| |**NET ASSETS**|**1,397**|1,347| |**FUNDS**
6
Unrestricted funds|**1,397**|1,347| |**TOTAL FUNDS**|**1,397**|1,347| The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ............................................. P J Ciclitira - Trustee The notes form part of these financial statements Page 5 **CLINICAL RESEARCH TRUST** **Notes to the Financial Statements for the Year Ended 5 April 2022** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value. ## **Financial reporting standard 102 - reduced disclosure exemptions** The charity has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland': - the requirements of Section 7 Statement of Cash Flows. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. ## **Taxation** The charity is exempt from tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. continued... Page 6 **CLINICAL RESEARCH TRUST** **Notes to the Financial Statements - continued for the Year Ended 5 April 2022** ## **2. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 5 April 2022 nor for the year ended 5 April 2021. ## **Trustees' expenses** There were no trustees' expenses paid for the year ended 5 April 2022 nor for the year ended 5 April 2021. |**3.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
**EXPENDITURE ON**
**Charitable activities**
Grants
Other|Unrestricted
fund
£
50,377
49,540
873| |---|---| |**Total**|50,413| |**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
**Total funds brought forward**|(36)
1,383| |**TOTAL FUNDS CARRIED FORWARD**|1,347| continued... Page 7 **CLINICAL RESEARCH TRUST** **Notes to the Financial Statements - continued for the Year Ended 5 April 2022** **----- Start of picture text -----**
4. FIXED ASSET INVESTMENTS
Listed
investments
£
MARKET VALUE
At 6 April 2021 and 5 April 2022 2,160
NET BOOK VALUE
At 5 April 2022 2,160
At 5 April 2021 2,160
There were no investment assets outside the UK.
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£ £
Trade creditors 840 840
Other creditors (72) 864
768 1,704
6. MOVEMENT IN FUNDS
Net
movement At
At 6/4/21 in funds 5/4/22
£ £ £
Unrestricted funds
General fund 1,347 50 1,397
TOTAL FUNDS 1,347 50 1,397
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 27,166 (27,116) 50
TOTAL FUNDS 27,166 (27,116) 50
**----- End of picture text -----**
continued... Page 8 **CLINICAL RESEARCH TRUST** **Notes to the Financial Statements - continued for the Year Ended 5 April 2022** ## **6. MOVEMENT IN FUNDS - continued** ## **Comparatives for movement in funds** |At 6/4/20
£
**Unrestricted funds**
General fund
1,383|Net
movement
At
in funds
5/4/21
£
£
(36)
1,347| |---|---| |**TOTAL FUNDS**
1,383|(36)
1,347| Comparative net movement in funds, included in the above are as follows: |**Unrestricted funds**
General fund|Incoming
Resources
resources
expended
£
£
50,377
(50,413)|Movement
in funds
£
(36)| |---|---|---| |**TOTAL FUNDS**|50,377
(50,413)|(36)| A current year 12 months and prior year 12 months combined position is as follows: |At 6/4/20
£
**Unrestricted funds**
General fund
1,383|Net
movement
At
in funds
5/4/22
£
£
14
1,397| |---|---| |**TOTAL FUNDS**
1,383|14
1,397| continued... Page 9 **CLINICAL RESEARCH TRUST** **Notes to the Financial Statements - continued for the Year Ended 5 April 2022** ## **6. MOVEMENT IN FUNDS - continued** A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |**Unrestricted funds**
General fund|Incoming
Resources
resources
expended
£
£
77,543
(77,529)|Movement
in funds
£
14| |---|---|---| |**TOTAL FUNDS**|77,543
(77,529)|14| ## **7. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 5 April 2022. Page 10 **CLINICAL RESEARCH TRUST** **Detailed Statement of Financial Activities for the Year Ended 5 April 2022** |**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
**Total incoming resources**
**EXPENDITURE**
**Charitable activities**
Grants to institutions
**Support costs**
**Finance**
Sundries
**Governance costs**
Accountancy
Total resources expended
**Net income/(expenditure)**|2022
£
**27,166**
**27,166**
**27,173**
**879**
**(936)**
**27,116**
**50**|2021
£
50,377
50,377
49,540
-
873
50,413
(36)| |---|---|---| This page does not form part of the statutory financial statements Page 11